Corinne Benchimol, DO

Clinical Focus

• Congenital Kidney Disease
• Dialysis
• Kidney Biopsy
• Kidney Function Tests
• Kidney Transplant
• Multicystic Dysplastic Kidney
• Pyelonephritis
• Solitary Kidney

• Congenital Kidney Disease
• Dialysis
• Kidney Biopsy
• Kidney Function Tests
• Kidney Transplant
• Multicystic Dysplastic Kidney
• Pyelonephritis
• Solitary Kidney

Locations

Mount Sinai Doctors Faculty Practice

5 East 98th Street, 10th Floor, New York, NY, 10029

212-241-6187

Mount Sinai Union Square

10 Union Square East, Suite 5M, New York, NY, 10003

212-844-8300

Elmhurst Hospital

79-01 Broadway, Queens, NY, 11373

718-334-4000

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Selected Publications

• COL4A4 variant recently identified: lessons learned in variant interpretation—a case report. Jenelle Cocorpus, Megan M. Hager, Corinne Benchimol, Vanesa Bijol, Fadi Salem, Sumit Punj, Laura Castellanos, Pamela Singer, Christine B. Sethna, Abby Basalely. BMC Nephrology
• Anti-glomerular basement membrane disease. Corinne Benchimol.
• Tolerability of up to 200 days of prophylaxis with valganciclovir oral solution and/or film-coated tablets in pediatric kidney transplant recipients at risk of cytomegalovirus disease. G. Varela-Fascinetto, C. Benchimol, R. Reyes-Acevedo, M. Genevray, D. Bradley, J. Ives, H. T. Silva. Pediatric Transplantation

Industry Relationships